Kristin Abate, Chief Accounting Officer: Karyopharm Therapeutics KPTI Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $449.82
Shares · price: 378 sh · $1.19 a share
Held after: 23,404 sh
Stock: Karyopharm Therapeutics KPTI
Person: Kristin AbateChief Accounting Officer
Trade date: 26/10/01
Filed: 26/10/02
Days to filing: 1 days

Sold 1.6% of holdings

Share of holding sold: 1.6%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 09/01~10/31

Kristin Abate's recent trades

Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$504
53 sh
$504
Filed 05/15
Traded 05/14
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$5,260
559 sh
$5,260
Filed 03/03
Traded 03/02
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$352
50 sh
$352
Filed 01/29
Traded 01/28
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$1,579
265 sh
$1,579
Filed 01/22
Traded 01/21
Kristin AbateChief Accounting Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,281
362 sh
$2,281
Filed 25/10/03
Traded 25/10/01